Stay updated on Nefecon in Primary IgA Nephropathy: Clinical Trial
Sign up to get notified when there's something new on the Nefecon in Primary IgA Nephropathy: Clinical Trial page.

Latest updates to the Nefecon in Primary IgA Nephropathy: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial on Nefecon for primary IgA nephropathy, while also updating the version number from v2.14.4 to v2.15.0.SummaryDifference9%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.8%
Stay in the know with updates to Nefecon in Primary IgA Nephropathy: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nefecon in Primary IgA Nephropathy: Clinical Trial page.